Thimble Point Acquisition (THMA) Stock Price, News & Analysis

Company Overview

Thimble Point Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New Haven, Connecticut.

Key Stats

• Today's Range: N/A
• 50-Day Range: $4.31 to $10.00
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 154,984 shs
• Market Capitalization: $2 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

THMA Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Thimble Point Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Thimble Point Acquisition investors own include Applied Therapeutics (APLT), Nascent Biotech (NBIO), Vector Group (VGR), Arista Networks (ANET), Ameriprise Financial (AMP), Advanced Micro Devices (AMD) and Amcor (AMCR).

Company Calendar

• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:THMA
• CIK: 1835567
• Web: N/A
• Phone: 203-680-8543
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.29
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($3.12) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,211,000
• Free Float: N/A
• Market Cap: $2 thousand
• Optionable: Not Optionable
• Beta: N/A